结直肠癌、肠道菌群与中医药:系统综述
本系统综述基于结直肠癌发病机制、肠道菌群种类与功能及其调控疾病发生发展的研究,探讨中医药通过调节肠道菌群治疗结直肠癌的机制。肠道菌群与宿主健康相关,中药复方、单味药材及单体成分可通过调节肠道菌群治疗结直肠癌,如逍遥散可增加拟杆菌属、乳杆菌属和变形杆菌属丰度,降低脱硫弧菌属和里克菌属丰度。
要点
- 肠道菌群失衡是结直肠癌发病机制之一,中药可通过调节菌群发挥治疗作用。
- 逍遥散可增加拟杆菌属、乳杆菌属和变形杆菌属丰度,降低脱硫弧菌属和里克菌属丰度。
- 中药复方、单味药材及单体成分均可通过调控肠道菌群治疗结直肠癌。
核心结论
- 研究肠道菌群对结直肠癌的调控及机制对疾病治疗大有裨益。
- 中药复方、单味药材和单体成分可通过调节肠道菌群治疗结直肠癌。
研究设计与样本
- 系统综述,基于结直肠癌发病机制、肠道菌群种类与功能及其调控疾病的研究进行总结。
主要发现
- 结直肠癌主要发病机制包括遗传变异、先天性和适应性免疫反应异常、黏膜屏障功能障碍、肠道微生物定植失衡及个人和环境风险因素。
- 肠道菌群主要包括硬壁菌门(含梭菌属、肠球菌属、乳杆菌属和瘤胃球菌属)和拟杆菌门(含拟杆菌属和普雷沃菌属),具有生物拮抗、营养、代谢、免疫刺激和塑造癌症基因等功能。
- 逍遥散可增加拟杆菌属、乳杆菌属和变形杆菌属丰度,降低脱硫弧菌属和里克菌属丰度。
临床怎么用
- 临床可考虑通过调节肠道菌群来治疗结直肠癌,如使用逍遥散等中药。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Based on the study and research on the pathogenesis of colorectal cancer, the types and functions of gut microbiota, and its role in guiding and regulating the occurrence and development of diseases, we have explored the mechanism of traditional Chinese medicine in the treatment of colorectal cancer by regulating the gut microbiota. Genetic variation, abnormal responses of innate and adaptive immunity, mucosal barrier dysfunction, imbalance of intestinal microbial colonization, personal and environmental risk factors are the main pathogenesis of colorectal cancer. The gut microbiota mainly includes Sclerotium (including Clostridium, Enterococcus, Lactobacillus and Ruminococcus) and Bacteroides (including Bacteroides and Prevotella), which have biological antagonism, nutrition for the organism, metabolic abilities, immune stimulation, and ability to shape cancer genes functions to body. The gut microbiota can be related to the health of the host. Current studies have shown that Chinese herbal compound, single medicinal materials, and monomer components can treat colorectal cancer by regulating the gut microbiota, such as Xiaoyaosan can increase the abundance of Bacteroides, Lactobacillus, and Proteus and decrease the abundance of Desulfovibrio and Rickerella. Therefore, studying the regulation and mechanism of gut microbiota on colorectal cancer is of great benefit to disease treatment.
引用
- Zhao H, He M, Zhang M, et al. Colorectal Cancer, Gut Microbiota and Traditional Chinese Medicine: A Systematic Review. Am J Chin Med. 2021. PMID: 33827382. doi:10.1142/S0192415X21500385
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。